Replies to post #28 on Medicis Pharmaceutical (MRX)

[brainlessone]

its always the same choice: safety or risk versus reward.

In this case, the more conservative company is actually taking a huge risk that the derm market will stay placid.

what about taro and chtt? are they similar in model as mrx? why have they performed so well